Coelho Luana Cassandra Breitenbach Barroso, Silva Priscila Marcelino Dos Santos, Lima Vera Lúcia de Menezes, Pontual Emmanuel Viana, Paiva Patrícia Maria Guedes, Napoleão Thiago Henrique, Correia Maria Tereza Dos Santos
Departamento de Bioquímica, Centro de Biociências, Universidade Federal de Pernambuco, Av. Prof. Moraes Rego 1235, Cidade Universitária, 50.670-901 Recife, PE, Brazil.
Departamento de Morfologia e Fisiologia Animal, Universidade Federal Rural de Pernambuco, Rua Dom Manuel de Medeiros, s/n, Dois Irmãos, 52171-900 Recife, PE, Brazil.
Evid Based Complement Alternat Med. 2017;2017:1594074. doi: 10.1155/2017/1594074. Epub 2017 Mar 7.
Lectins are proteins extensively used in biomedical applications with property to recognize carbohydrates through carbohydrate-binding sites, which identify glycans attached to cell surfaces, glycoconjugates, or free sugars, detecting abnormal cells and biomarkers related to diseases. These lectin abilities promoted interesting results in experimental treatments of immunological diseases, wounds, and cancer. Lectins obtained from virus, microorganisms, algae, animals, and plants were reported as modulators and tool markers in vivo and in vitro; these molecules also play a role in the induction of mitosis and immune responses, contributing for resolution of infections and inflammations. Lectins revealed healing effect through induction of reepithelialization and cicatrization of wounds. Some lectins have been efficient agents against virus, fungi, bacteria, and helminths at low concentrations. Lectin-mediated bioadhesion has been an interesting characteristic for development of drug delivery systems. Lectin histochemistry and lectin-based biosensors are useful to detect transformed tissues and biomarkers related to disease occurrence; antitumor lectins reported are promising for cancer therapy. Here, we address lectins from distinct sources with some biological effect and biotechnological potential in the diagnosis and therapeutic of diseases, highlighting many advances in this growing field.
凝集素是一类蛋白质,因其具有通过碳水化合物结合位点识别碳水化合物的特性,被广泛应用于生物医学领域。这些位点能够识别附着在细胞表面、糖缀合物或游离糖上的聚糖,从而检测与疾病相关的异常细胞和生物标志物。凝集素的这些特性在免疫疾病、伤口和癌症的实验性治疗中取得了令人感兴趣的结果。据报道,从病毒、微生物、藻类、动物和植物中获得的凝集素在体内和体外可作为调节剂和工具标记物;这些分子在诱导有丝分裂和免疫反应中也发挥作用,有助于解决感染和炎症问题。凝集素通过诱导伤口再上皮化和瘢痕形成显示出愈合效果。一些凝集素在低浓度下对病毒、真菌、细菌和蠕虫具有有效的作用。凝集素介导的生物粘附是药物递送系统开发中一个有趣的特性。凝集素组织化学和基于凝集素的生物传感器可用于检测与疾病发生相关的转化组织和生物标志物;报道的抗肿瘤凝集素在癌症治疗方面具有前景。在此,我们探讨了来自不同来源的凝集素在疾病诊断和治疗中的一些生物学效应和生物技术潜力,突出了这个不断发展的领域中的许多进展。